Researchers created an experimental treatment for von Willebrand disease (VWD) type 1 that aims to stabilize the protein whose defect causes the disease, increasing its activity to help normalize blood clotting. The team described the development and preclinical proof of concept for their new treatment in the study, “…
Read more
Switching from treatment with fresh frozen plasma (FFP) to Adzynma (ADAMTS13, recombinant-krhn) can help people with congenital thrombotic thrombocytopenic purpura (TTP) avoid hospital stays,…
The back of my left hand, the top of my right knee, my left shin, left calf muscle, right thumb, the top of my left…
